- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06197477
Indoor Air Quality Monitoring and Impact on Children's Health (LEARN)
January 8, 2024 updated by: Tim Nawrot, Hasselt University
Development of Novel Assessments for Indoor Air Quality Monitoring and Impact on Children's Health - Cohorts in Schools & Biomarkers of Exposure
This study aims at understanding the relation between indoor air quality in schools, including both chemical and microbiological determinants, and cognition in children by gathering data across different parts of Europe
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The LEARN project, funded by the European Commission, aims to gain an in-depth understanding about indoor air quality in schools and its impact on children's cognitive development.
This involves evaluating school cohorts in three different countries (Belgium, Greece and Denmark).
In participating schools, we measure and characterise indoor and outdoor air pollutants and evaluate the presence of exposure biomarkers and their effect on children's cognition.
Measuring indoor air quality, exposure and creating remedial strategies are crucial steps to improve air quality in the school environment and ensure the well-being of children.
Study Type
Interventional
Enrollment (Estimated)
900
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rossella Alfano, PhD
- Phone Number: +3281739400
- Email: rossella.alfano@uhasselt.be
Study Contact Backup
- Name: Nawrot
Study Locations
-
-
-
Diepenbeek, Belgium, 3590
- Recruiting
- Hasselt University
-
Contact:
- Rossella Alfano
-
Principal Investigator:
- Tim Nawrot
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Boys and girls
- Attending school in the 4th -6th grade in elementary schools included in the study
- Signed informed consent form by legal representative
Exclusion Criteria:
- Insufficient knowledge of local language (ie. Dutch, Greek, Danish) by child or parents
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Air purification
The intervention will consist of air purification placed in the classrooms.
|
Filtration device will be placed in classrooms.
Computational Fluid Dynamics simulations will be used to find optimal position and operation mode for air purification systems in classrooms.
|
|
Sham Comparator: Control
Filtration will be turned off in the air purifier placed in the classrooms in the control part of the study.
|
Filtration will be turned off in the control part of the study and then will be turned on during the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Correct Detection of continuous Performance Test
Time Frame: at the end of the intervention and at the end of the sham intervention
|
Change in the number of times the child responded correctly to the target alphanumeric stimulus.
Higher rates of correct detections indicate better attentional capacity.
|
at the end of the intervention and at the end of the sham intervention
|
|
Change in the number of correct substitutions of Symbol Digit Modalities Test
Time Frame: at the end of the intervention and at the end of the sham intervention
|
Change in the the number of correct substitutions the child performed.
Higher number of correct substitutions indicate better information processing ability.
|
at the end of the intervention and at the end of the sham intervention
|
|
Change in the Memory Span Task score
Time Frame: at the end of the intervention and at the end of the sham intervention
|
Change in the number of longest list of items that a child can repeat back in correct order.
Longer list of recalled items indicate better short term memory
|
at the end of the intervention and at the end of the sham intervention
|
|
Change in the Signal Detection Test score
Time Frame: at the end of the intervention and at the end of the sham intervention
|
Change in the number of correct detection of signals.
Higher rates of correct detection indicate better perception ability
|
at the end of the intervention and at the end of the sham intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tim Nawrot, PhD, Hasselt University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 20, 2023
Primary Completion (Estimated)
December 1, 2025
Study Completion (Estimated)
December 1, 2025
Study Registration Dates
First Submitted
September 28, 2023
First Submitted That Met QC Criteria
January 8, 2024
First Posted (Actual)
January 9, 2024
Study Record Updates
Last Update Posted (Actual)
January 9, 2024
Last Update Submitted That Met QC Criteria
January 8, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Hasselt University
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cognition
-
Westlake UniversityThe Third People's Hospital of Hangzhou; Affiliated Hangzhou First People's...Not yet recruiting
-
Huashan HospitalChinese Academy of SciencesRecruiting
-
RenJi HospitalShanghai Jiao Tong University School of MedicineRecruiting
-
Eunice Kennedy Shriver National Institute of Child...National Institutes of Health Clinical Center (CC); United States Department... and other collaboratorsCompletedCognitionUnited States
-
University of MinnesotaUniversity of California, San Francisco; Posit Science CorporationCompleted
-
GlaxoSmithKlineCompleted
-
University Hospital, GrenobleTerminated
-
Newcastle UniversityCompleted
-
GlaxoSmithKlineCambridge Cognition LtdCompleted
-
University of LeedsWelch's, Inc.Completed